← Back to exploreEntelexo Biotherapeutics
Healthcare & Life Sciences~3 peopleIrvine, CA, USA
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
Funding Timeline
No funding rounds recorded yet.
Signals
- Pressurl: https://news.google.com/rss/articles/CBMiVkFVX3lxTE02MzJ3dXRJU2tYTXFqcWZXOEFGUGZieG03T1dTS3A3S1JSb3pIM1R3VnA0LXRuaWxwYW5aVWk5djNjcDluQ28zLThvTmJMMTdHNUtrSHd3?oc=5 · headline: Entelexo Biotherapeutics Revenue 2024: $5M Est. ARR · publication: GetLatkagoogle_news · 9/15/2026